Clinical parameters in severe asthma

E-poster session
Chairs: D. Jackson (London, United Kingdom), R. Louis (Liège, Belgium)

Patient-reported versus objective adherence and exacerbation rates in severe asthma. J. King (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), L. Holmes (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), L. Elsey (Manchester (Greater Manchester), United Kingdom)
Practicality and clinical utility of cardiopulmonary exercise testing to investigate complex breathlessness in severe asthma A. Vigus (Birmingham (West Midlands), United Kingdom), M. Thomas (Birmingham (West Midlands), United Kingdom), A. Mansur (Birmingham (West Midlands), United Kingdom)
Targeted literature review: epidemiology of severe and uncontrolled asthma and associated biomarkers in France, Germany, Italy, Spain and the UK A. Quinton (Cambridge, United Kingdom), L. Callan (Cambridge, United Kingdom), J. Dube (Burlington, ON, Canada), S. Singh (Burlington, ON, Canada), A. Bourdin (Montpellier, France)
A “gender phenotype” does really exist in severe asthma. S. Rizzello (Firenze (FI), Italy), C. Allegrini (Firenze (FI), Italy), L. Ciambellotti (Firenze (FI), Italy), C. De Filippis (Firenze (FI), Italy), F. Lavorini (Firenze (FI), Italy), G. Camiciottoli (Firenze (FI), Italy)
Small airway evolution of a Brazilian severe asthmatic cohort (BRASASP): 10 years follow up N. Gonçalves Dos Santos Junior (Sao Paulo (SP), Brazil), R. Miranda Lima (Sao Paulo (SP), Brazil), R. Abensur Athanazio (Sao Paulo (SP), Brazil), R. Maria De Carvalho Pinto (Sao Paulo (SP), Brazil), J. Salge (Sao Paulo (SP), Brazil), K. Rabe (SGrosshansdorf, Germany), A. Cukier (Sao Paulo (SP), Brazil), R. Stelmach (Sao Paulo (SP), Brazil)
Real prevalence of severe asthma in developing countries – Is the diagnosis correct? M. Chopra (Delhi, India), V. Vardhan (Delhi, India), P. Singh (Delhi, India)
Association between cough frequency and T2 inflammation in severe asthma J. Holmes (Belfast, United Kingdom), S. Birring (London, United Kingdom), H. Fletcher (London, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom)
The Cretan Registry of the use of Biologics in Severe Asthma (CREBS) of the University Hospital of Heraklion,Greece K. Antoniou (Heraklion, Greece), M. Bolaki (Heraklion, Greece), K. Karagiannis (Heraklion, Greece), D. Ierodiakonou (Heraklion, Greece), V. Stamatopoulou (Heraklion, Greece), A. Trachalaki (London, United Kingdom), C. Chatzinikolaou (Heraklion, Greece), E. Vakouti (Crete, Greece), E. Vlachaki (Crete, Greece), T. Solakis (Crete, Greece), M. Markatos (Crete, Greece), S. Vittorakis (Crete, Greece), A. Kostaki (Crete, Greece), M. Varoucha (Crete, Greece), E. Stamataki (Heraklion, Greece), G. Pitsidianakis (Heraklion, Greece), I. Lambiri (Heraklion, Greece), I. Mitrouska (Heraklion, Greece), N. Tzanakis (Heraklion, Greece)
Cretan Severe Asthma Registry K. Antoniou (Heraklion, Greece), K. Karagiannis (Heraklion, Greece), M. Bolaki (Heraklion, Greece), D. Ierodiakonou (Heraklion, Greece), A. Trachalaki (London, United Kingdom), V. Stamatopoulou (Heraklion, Greece), C. Chatzinikolaou (Heraklion, Greece), E. Vakouti (Crete, Greece), E. Vlachaki (Crete, Greece), A. Kostaki (Crete, Greece), M. Varoucha (Crete, Greece), T. Solakis (Crete, Greece), M. Markatos (Crete, Greece), S. Vittorakis (Crete, Greece), E. Stamataki (Heraklion, Greece), G. Pitsidianakis (Heraklion, Greece), I. Lambiri (Heraklion, Greece), I. Mitrouska (Heraklion, Greece), N. Tzanakis (Heraklion, Greece)
The relationship between lung function and BAL return in severe asthma D. Hill (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), C. Newell (Southampton, United Kingdom), A. Azim (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom), T. Wallis (Southampton, United Kingdom), A. Freeman (Southampton, United Kingdom)
Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom)
Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK A. Bourdin (Montpellier, France), A. Quinton (Cambridge, United Kingdom), L. Callan (Cambridge, United Kingdom), J. Dube (Burlington, ON, Canada), M. Wu (Burlington, ON, Canada), S. Singh (Burlington, ON, Canada)
Relation between pulmonary function tests (PFTs) and severe asthma difficult to control B. Urizar Catalan (Huelva, Spain), M. Morón Ortiz (Huelva, Spain), C. Puchaes Manchón (Huelva, Spain), J. Romero Lopez (Huelva, Spain), A. Pereira-Vega (Huelva, Spain), J. Sanchez Ramos (Huelva, Spain)
Diagnosis of Endoscopic Patterns in Severe Asthma L. Mendez Mangas (Hospitalet de Llobregat, Spain), E. Fontanilles Arbones (Hospitalet de Llobregat, Spain), M. Diez Ferrer (Hospitalet de Llobregat, Spain), C. Martin Cabeza (Hospitalet de Llobregat, Spain), N. Cubero De Frutos (Hospitalet de Llobregat, Spain), S. Santos Perez (Hospitalet de Llobregat, Spain), J. Dorca Sargatal (Hospitalet de Llobregat, Spain), R. Lopez Lisbona (Hospitalet de Llobregat, Spain), M. Muñoz Esquerre (Hospitalet de Llobregat, Spain)
Personalizing asthma care base on Asthma Control Test (ACT) correlation with treatment of asthma comorbidities in a Malaysian cohort N. Yaqeen (Kuala Lumpur, Malaysia), A. Ismail (Sungai Buloh Lumpur, Malaysia)
The first 30 months of the Portuguese Severe Asthma Registry A. Sá-Sousa (Porto, Portugal), R. Brás (Lisboa, Portugal), L. Amaral (Porto, Portugal), A. Mendes (Lisboa, Portugal), W. Videira (Lisboa, Portugal), C. Pardal (Amadora; Cascais, Portugal), J. Alberto Ferreira (VNGaia, Portugal), A. Sokolova (Amadora, Portugal), C. Chaves Loureiro (Coimbra, Portugal), E. Faria (Coimbra, Portugal), A. Arrobas (Coimbra, Portugal), C. Lopes (Matosinhos; Porto, Portugal), L. Ribeiro (Vila Real, Portugal), M. Mesquita (VNGaia, Portugal), I. Silva (Lisboa, Portugal), M. Drummond (Porto, Portugal), N. Santos (Faro, Portugal), P. Alendouro (Guimarães, Portugal), P. Carreiro-Martins (Lisboa, Portugal), R. Lima (VNGaia, Portugal), V. Caldeira (Lisboa, Portugal), J. A Fonseca (Porto, Portugal)
Effect of obstructive sleep apnea on asthma control D. Mat (Ankara, Turkey), S. Firat (Ankara, Turkey), K. Aksu (Ankara, Turkey), F. Aksu (Ankara, Turkey), S. Sahin Duyar (Ankara, Turkey)
Predictors of sputum eosinophilia in severe asthma A. Azim (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), M. Felongco (Southampton, United Kingdom), H. Wheeler (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom)
Quality of life in severe asthma measured by SAQ and EQ5D questionnaires as a function of clinically relevant cut off points J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom)